JP2013186124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013186124A5 JP2013186124A5 JP2013043157A JP2013043157A JP2013186124A5 JP 2013186124 A5 JP2013186124 A5 JP 2013186124A5 JP 2013043157 A JP2013043157 A JP 2013043157A JP 2013043157 A JP2013043157 A JP 2013043157A JP 2013186124 A5 JP2013186124 A5 JP 2013186124A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- gpibα
- vwf
- solid phase
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12158022.9A EP2637024A1 (de) | 2012-03-05 | 2012-03-05 | Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion |
| EP12158022.9 | 2012-03-05 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013186124A JP2013186124A (ja) | 2013-09-19 |
| JP2013186124A5 true JP2013186124A5 (https=) | 2016-03-03 |
| JP6199050B2 JP6199050B2 (ja) | 2017-09-20 |
Family
ID=47722189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013043157A Active JP6199050B2 (ja) | 2012-03-05 | 2013-03-05 | ＧＰＩｂ−フォン・ヴィレブランド因子相互作用の機能障害を有する試料を見出すためのスクリーニング方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9766234B2 (https=) |
| EP (2) | EP2637024A1 (https=) |
| JP (1) | JP6199050B2 (https=) |
| ES (1) | ES2575778T3 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007031708A1 (de) * | 2007-07-06 | 2009-01-08 | Dade Behring Marburg Gmbh | Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin |
| EP2637024A1 (de) | 2012-03-05 | 2013-09-11 | Siemens Healthcare Diagnostics Products GmbH | Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion |
| ES2614352T3 (es) * | 2014-03-11 | 2017-05-30 | Siemens Healthcare Diagnostics Products Gmbh | Método para la detección de moduladores de la interacción de GPIb-trombina |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4380067B2 (ja) * | 1998-04-23 | 2009-12-09 | 味の素株式会社 | 抗血栓活性物質及びグリコカリシンの検出法 |
| ATE497171T1 (de) | 1999-07-05 | 2011-02-15 | Leuven K U Res & Dev | Von willebrand-faktor-aktivitätsnachweis |
| DE102006019520A1 (de) * | 2006-04-27 | 2007-11-08 | Dade Behring Marburg Gmbh | Verfahren zur Bestimmung hoher Ristocetin-Kofaktor-Aktivitäten des von-Willebrand-Faktors |
| DE102007031708A1 (de) * | 2007-07-06 | 2009-01-08 | Dade Behring Marburg Gmbh | Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin |
| EP2193373A4 (en) | 2007-08-23 | 2010-07-28 | Bloodct Of Wisconsin Inc | METHODS AND KITS FOR MEASURING VON WILLEBRAND FACTOR |
| EP2637024A1 (de) | 2012-03-05 | 2013-09-11 | Siemens Healthcare Diagnostics Products GmbH | Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion |
-
2012
- 2012-03-05 EP EP12158022.9A patent/EP2637024A1/de not_active Withdrawn
-
2013
- 2013-02-25 ES ES13156498.1T patent/ES2575778T3/es active Active
- 2013-02-25 EP EP13156498.1A patent/EP2637025B1/de active Active
- 2013-02-28 US US13/779,904 patent/US9766234B2/en active Active
- 2013-03-05 JP JP2013043157A patent/JP6199050B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015038884A3 (en) | Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products | |
| MX2017011489A (es) | Detección de moléculas pequeñas mediante nanoporos a través de ensayos de competición. | |
| ZA202002415B (en) | Detection of symmetrical dimethylarginine | |
| JP2016516735A5 (https=) | ||
| EA201490745A1 (ru) | Полипептиды антител, которые вызывают антагонизм cd40l | |
| CN102892885B (zh) | IgA结合性肽以及利用其的IgA的纯化 | |
| JP2012517017A5 (https=) | ||
| RU2015120601A (ru) | Эритроферрон и erfe-полипептиды и способы регуляции метаболизма железа | |
| JP2013511530A5 (https=) | ||
| Li et al. | Identification of IgE and IgG epitopes on native Bos d 4 allergen specific to allergic children | |
| BR112015022844A2 (pt) | métodos para detecção de anticorpos para doadores específicos e sistemas para pratica destes | |
| JP2016528236A5 (https=) | ||
| JP2016520846A5 (https=) | ||
| WO2015006337A3 (en) | Compositions and methods for increasing protein half-life in a serum | |
| JP2017510627A5 (https=) | ||
| JP2020521460A5 (https=) | ||
| JP2013186124A5 (https=) | ||
| JP2015529211A5 (https=) | ||
| Reese et al. | Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands | |
| JP6457933B2 (ja) | インスリン測定方法 | |
| Vagida et al. | Flow analysis of individual blood extracellular vesicles in acute coronary syndrome | |
| WO2012126118A8 (en) | Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy | |
| JP6515923B2 (ja) | クレアチンキナーゼｍｂアイソザイムの測定方法及びそれに用いられるキット | |
| JP2014524583A5 (https=) | ||
| JP2017538786A5 (https=) |